tirzepatide patent challenge HIMS $LLY $NVO 🚨 BREAKING: BPI LABS IS CHALLENGING ELI LILLY'S "CROWN JEWEL" - This follows Empower Pharmacy's petition challenging the same '780 patent Tirzepatide | New Drug Approvals

A higher-dose formulation for weight management is marketed separately as Zepbound in some regions

Please report the study drug condition to the study team at [email protected] and follow the provided steps on returning unused medication

Tirzepatide is a novel medication that acts as a dual GLP-1 and GIP receptor agonist, primarily designed for managing type 2 diabetes and assisting in weight loss

Patients should discuss realistic expectations with their provider

Gallstones and biliary sludge are known triggers for acute pancreatitis, potentially creating an indirect pathway between these medications and pancreatic inflammation in some patients

This prevents accidentally using a vial past its recommended timeline